drugset

drugset / Trial / NCT00582712

An Initial Study of Lithium in Patients With Medullary Thyroid Cancer

NCT00582712 ↗

Phase 2 Terminated 5 enrolled University of Wisconsin, Madison

NaSingle-groupOpen-labelTreatment

Summary

Primary objective is to evaluate the tumor response rate of patients with MTC treated with Lithium carbonate

Timeline

Start: 2008-01
Primary completion: 2009-05
Completion: 2012-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lithium	Unknown	300 mg	Oral

Indications